The potential of inhibiting glutamine uptake as a therapeutic target for multiple myeloma

被引：20
|
作者：
Giuliani, Nicola [1 ]
Chiu, Martina [2 ]
Bolzoni, Marina [1 ]
Accardi, Fabrizio [1 ]
Bianchi, Massimiliano G. [2 ]
Toscani, Denise [1 ]
Aversa, Franco [1 ]
Bussolati, Ovidio [2 ]
机构：
[1] Univ Parma, Dept Clin & Expt Med, Parma, Italy
[2] Univ Parma, Dept Biomed Biotechnol & Translat Sci, Parma, Italy
来源：
EXPERT OPINION ON THERAPEUTIC TARGETS | 2017年 / 21卷 / 03期
关键词：
Multiple myeloma; glutamine; metabolism; target therapy; ASCT2; CANCER; CELLS; METABOLISM; GROWTH; TRANSPORTERS; ADDICTION; STRESS; MTORC1;
D O I：
10.1080/14728222.2017.1279148
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：231 / 234
页数：4
相关论文
共 50 条
  • [41] Centrosomal Clustering - a Novel Therapeutic Target for Multiple Myeloma
    Raab, Marc S.
    Breitkreutz, Iris
    Rebacz, Blanka
    Larsen, Thomas O.
    Wagner, Ludmila
    Hayden, Patrick
    Ho, Anthony D.
    Clausen, Mads H.
    Goldschmidt, Hartmut
    Anderson, Kenneth C.
    Kreamer, Alwin
    BLOOD, 2009, 114 (22) : 126 - 126
  • [42] Emerging pathways as individualized therapeutic target of multiple myeloma
    Misso, Gabriella
    Zappavigna, Silvia
    Castellano, Maria
    De Rosa, Giuseppe
    Di Martino, Maria Teresa
    Tagliaferri, Pierosandro
    Tassone, Pierfrancesco
    Caraglia, Michele
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2013, 13 : S95 - S109
  • [43] Centrosomal Clustering: A Novel Therapeutic Target for Multiple Myeloma
    Raab, M. S.
    Breitkreutz, I.
    Rebacz, B.
    Hayden, P. J.
    Larsen, T. O.
    Clausen, M. H.
    Fruehauf, J. H.
    Goldschmidt, H.
    Anderson, K. C.
    Kraemer, A.
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S153 - S153
  • [44] Possible Therapeutic Potential of Disulfiram for Multiple Myeloma
    Weiser Drozdkova, Denisa
    Smesny Trtkova, Katerina
    CURRENT ONCOLOGY, 2021, 28 (03) : 2087 - 2096
  • [45] CD26 is a potential therapeutic target by humanized monoclonal antibody for the treatment of multiple myeloma
    Nishida, Hiroko
    Hayashi, Mutsumi
    Morimoto, Chikao
    Sakamoto, Michiie
    Yamada, Taketo
    BLOOD CANCER JOURNAL, 2018, 8
  • [46] Functional expression of aryl hydrocarbon receptor as a potential novel therapeutic target in human multiple myeloma
    Hughes, Tiffany
    Cottini, Francesca
    Catton, Evan
    Ciarlariello, David
    Chen, Luxi
    Yang, Yiping
    Liu, Bei
    Mundy-Bosse, Bethany L.
    Benson, Don M.
    LEUKEMIA & LYMPHOMA, 2021, 62 (12) : 2968 - 2980
  • [47] Exosomal circRNA as a novel potential therapeutic target for multiple myeloma-related peripheral neuropathy
    Zhang, Yanyu
    Pisano, Michael
    Li, Nianhu
    Tan, Guoqing
    Sun, Fumou
    Cheng, Yan
    Zhang, Yanyan
    Cui, Xing
    CELLULAR SIGNALLING, 2021, 78
  • [48] Chromosome 1 instability in multiple myeloma: Aberrant gene expression, pathogenesis, and potential therapeutic target
    Luo, Saiqun
    Su, Tao
    Zhou, Xiang
    Hu, Wei-Xin
    Hu, Jingping
    FASEB JOURNAL, 2022, 36 (06):
  • [49] SMAD1 as a biomarker and potential therapeutic target in drug-resistant multiple myeloma
    Wu, Jian
    Zhang, Min
    Faruq, Omar
    Zacksenhaus, Eldad
    Chen, Wenming
    Liu, Aijun
    Chang, Hong
    BIOMARKER RESEARCH, 2021, 9 (01)
  • [50] CD26 is a potential therapeutic target by humanized monoclonal antibody for the treatment of multiple myeloma
    Hiroko Nishida
    Mutsumi Hayashi
    Chikao Morimoto
    Michiie Sakamoto
    Taketo Yamada
    Blood Cancer Journal, 8
12345